Recent findings about EMT documented that gene amplification of SMO, a Hh receptor, is another mechanism of acquired resistance to first-generation EGFR-TKIs in EGFR-mutant NSCLC cells [153]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.